```html

Migraine – Comprehensive Medical Guide

Overview

A migraine is a neurological disorder characterized by recurrent, moderate‑to‑severe headaches that are often accompanied by a range of sensory disturbances. Migraine attacks typically last from 4 to 72 hours if untreated and can be disabling.

Who it affects: Migraines are most common in people between the ages of 25‑55, but they can begin in childhood or persist into older adulthood. Women are three to four times more likely to experience migraine than men, largely due to hormonal influences.

Prevalence: According to the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), migraine affects about 15 % of the global population—roughly 1 in 7 people. In the United States, an estimated 39 million adults report having migraine each year (CDC, 2023)【1】.

Symptoms

Migraine symptoms vary widely between individuals and even between attacks. The International Classification of Headache Disorders (ICHD‑3) outlines the following typical features:

Headache Characteristics

• Pulsating or throbbing quality—often feels like a “heartbeat” in the head.
• Unilateral location—most commonly on one side, though it can become bilateral.
• Moderate to severe intensity—often described as “worst headache of my life.”
• Aggravated by routine physical activity—walking or climbing stairs can worsen pain.

Aura (experienced by ~25 % of migraineurs)

• Visual disturbances: flashing lights, zig‑zag lines, blind spots, or temporary vision loss.
• Somatosensory aura: tingling or numbness, usually starting in the hand and spreading up the arm.
• Speech or language aura: difficulty finding words or forming sentences.
• These symptoms typically develop 5–60 minutes before the headache and resolve within an hour.

Associated Symptoms

• Nausea and/or vomiting
• Photophobia (sensitivity to light)
• Phonophobia (sensitivity to sound)
• Osmophobia (sensitivity to smells)
• Neck stiffness or tension
• Fatigue and “brain fog” after the attack (post‑drome)

Causes and Risk Factors

The exact cause of migraine is not fully understood, but research indicates a complex interaction between genetic, vascular, and neuro‑inflammatory pathways.

Genetic predisposition

• First‑degree relatives of migraine patients have a 2–4‑fold higher risk.
• Genome‑wide association studies have identified >40 migraine‑related loci (NIH, 2022)【2】.

Neurovascular mechanisms

• Activation of the trigeminovascular system releases calcitonin gene‑related peptide (CGRP), causing inflammation and vasodilation of cranial blood vessels.
• Fluctuations in brainstem serotonin levels influence pain pathways.

Common triggers (often modifiable)

• Hormonal changes – menstrual cycles, pregnancy, menopause, hormonal contraceptives.
• Sleep disturbances – too much or too little sleep.
• Dietary factors – aged cheese, processed meats, alcohol (especially red wine), caffeine overuse/withdrawal, artificial sweeteners.
• Environmental stimuli – bright or flickering lights, loud noises, strong odors.
• Stress and emotional upheaval.
• Physical factors – strenuous exercise, changes in weather or barometric pressure.

Risk factors

• Female sex (especially ages 20‑45)
• Family history of migraine
• History of anxiety or depression
• Obesity (BMI ≥ 30) – linked to higher frequency of attacks
• Smoking

Diagnosis

Migraine is primarily a clinical diagnosis. A thorough history and physical examination are essential.

Diagnostic steps

1. Detailed headache history: onset, duration, location, quality, aggravating/relieving factors, associated symptoms, aura presence, frequency.
2. Triggers and lifestyle review: diet, sleep, stress, menstrual cycle.
3. Neurological examination: ensures no focal deficits that would suggest secondary causes.

When imaging or labs are needed

If red‑flag signs are present (see “When to Seek Emergency Care”) or if the pattern changes, physicians may order:

• MRI of the brain – to rule out structural lesions, tumors, or demyelinating disease.
• CT scan – useful in acute settings for hemorrhage suspicion.
• Blood tests – complete blood count, ESR, CRP if infection or inflammation is a concern.

Most patients with classic migraine do not require imaging.

Treatment Options

Treatment is divided into acute (abortive) and preventive (prophylactic) strategies.

Acute (abortive) therapies

• NSAIDs (ibuprofen 400‑600 mg, naproxen 500 mg) – first‑line for mild‑moderate attacks.
• Acetaminophen – alternative if NSAIDs are contraindicated.
• Triptans (e.g., sumatriptan 50‑100 mg oral, rizatriptan 5‑10 mg) – serotonin 5‑HT<sub>1B/1D</sub> agonists, effective for moderate‑severe attacks.
• Gepants (ubrogepant, rimegepant) – CGRP receptor antagonists approved for acute treatment (FDA 2020).
• Ditans (lasmiditan) – 5‑HT<sub>1F</sub> agonist, useful for patients with cardiovascular risk where triptans are unsafe.
• Anti‑nausea agents (metoclopramide, prochlorperazine) – address vomiting and improve oral medication absorption.

Preventive (prophylactic) therapies

Considered when patients have ≥4 headache days per month, severe disability, or medication overuse.

• Beta‑blockers (propranolol, metoprolol) – widely used, especially in patients with hypertension.
• Antidepressants (amitriptyline, venlafaxine) – useful when comorbid mood disorders exist.
• Anticonvulsants (topiramate, valproate) – effective but monitor for side‑effects.
• CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) – administered quarterly or monthly, reduce migraine days by ~50 % (clinical trials, 2021)【3】.
• OnabotulinumtoxinA – 31 injections every 12 weeks; FDA‑approved for chronic migraine (>15 days/month).
• Lifestyle & behavioral interventions – biofeedback, cognitive‑behavioral therapy (CBT), relaxation training.

Procedural options for refractory cases

• Occipital nerve stimulation
• Transcranial magnetic stimulation (single‑pulse TMS)
• Greater occipital nerve block with corticosteroid

Living with Migraines

Effective self‑management can dramatically improve quality of life.

Daily habits

• Maintain a headache diary – record triggers, medication response, and sleep patterns.
• Regular sleep schedule – aim for 7‑9 hours, go to bed and wake at the same time.
• Hydration – drink 2‑3 L of water daily; dehydration is a known trigger.
• Balanced meals – avoid skipping meals; include protein, complex carbs, and healthy fats.
• Physical activity – moderate aerobic exercise (e.g., walking, swimming) most days; start slowly if you’re prone to exertional headache.

Stress management

• Practice mindfulness or meditation 10‑15 min daily.
• Consider CBT or counseling if anxiety/depression coexist.
• Schedule regular “relaxation breaks” during high‑stress periods.

Medication management

• Take acute meds early – at the first sign of a aura or mild pain.
• Avoid >10 days/month of triptans/NSAIDs to prevent medication‑overuse headache.
• Set reminders for preventive doses; discuss side‑effects with your clinician.

Work & social life

• Inform close coworkers or supervisors about your condition and possible need for a quiet space.
• Use “migraine kits” containing meds, water, sunglasses, and a cool compress.
• Plan social activities with flexibility—choose venues with dim lighting and low noise.

Prevention

Prevention combines trigger avoidance, lifestyle optimization, and prophylactic medication when indicated.

Identify and modify triggers

1. Food diary – log meals for 4‑6 weeks to spot pattern.
2. Environmental adjustments – use blue‑light filters, wear sunglasses outdoors, keep bedroom cool (18‑22 °C).
3. Hormonal management – discuss low‑dose estrogen patches or hormonal IUDs with a gynecologist if menstrual migraines predominate.

Evidence‑based preventive measures

• Regular aerobic exercise – 30 min, 3‑5 times/week reduces frequency by ~20 % (Cleveland Clinic, 2021)【4】.
• Magnesium supplementation – 400‑600 mg daily of magnesium oxide shown to decrease attack frequency (Cochrane Review, 2020)【5】.
• Riboflavin (Vitamin B2) – 400 mg daily may reduce severity in some patients.
• Coenzyme Q10 – 100‑300 mg daily has modest benefit.

Complications

When migraines are frequent or untreated, several complications can arise:

• Medication‑overuse headache – paradoxical worsening due to frequent analgesic use.
• Chronic migraine – ≥15 headache days/month for >3 months.
• Psychiatric comorbidities – higher rates of depression, anxiety, and sleep disorders.
• Reduced productivity – up to 13 % of workdays lost per year (CDC, 2022)【6】.
• Impaired quality of life – comparable to chronic conditions such as diabetes or heart disease.
• In rare cases, persistent aura may increase the risk of ischemic stroke, especially in women who smoke and use combined oral contraceptives.

When to Seek Emergency Care

---

Sources:

1. Centers for Disease Control and Prevention. Headache and Migraine. 2023. cdc.gov
2. National Institutes of Health. Genetics of Migraine. 2022. nih.gov
3. Goadsby PJ et al. “CGRP‑targeted monoclonal antibodies for migraine prevention.” NEJM. 2021;384:1271‑1282.
4. Cleveland Clinic. “Exercise and Migraine.” 2021. clevelandclinic.org
5. Schulman S, et al. “Magnesium for migraine prophylaxis.” Cochrane Database Syst Rev. 2020.
6. CDC. “Burden of Migraine in the United States.” 2022. cdc.gov

```